| Line Item | 2024-07-31 | Y/Y |
|---|---|---|
| R&D Expense | $0 | -100.0% |
| SG&A Expense | $1.5M | -29.0% |
| Operating Income | $14.3M | +368.4% |
| Income Tax | $0 | — |
| Net Income | -$842K | +85.8% |
| EPS (Basic) | -$0.01 | +85.7% |
| EPS (Diluted) | -$0.01 | +85.7% |
| Line Item | 2024-07-31 | Y/Y |
|---|---|---|
| Current Assets | $57K | -86.0% |
| Total Assets | $586K | +28.6% |
| Current Liabilities | $5.9M | -10.5% |
| Stockholders' Equity | -$5.3M | +13.4% |
| Line Item | 2024-07-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$1.2M | +17.6% |
| Investing Cash Flow | $1.0M | — |
| Financing Cash Flow | $181K | -87.5% |